ArticleExperimental and therapeutic medicine2023

Predictors of therapeutic response to peginterferon α‑2a and nucleos(t)ide analog combination therapy for HBeAg‑negative chronic hepatitis B: 1‑year follow‑up after treatment.

Shima Mimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.